UNSPSC 85512645: Restriction of superior mesenteric artery with extraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of superior mesenteric artery with extraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04V53CZ

UNSPSC 85512645 Restriction of superior mesenteric artery with extraluminal device, percutaneous approach (Commodity) shows a significant mismatch between its nominal medical-device scope and recent state and local contracting activity. The code has received no relevant procurement activity aligned with the implantable vascular device it nominally describes. Recent opportunities tagged to this code cover occupational medical surveillance, pharmacy benefit management, disability medical evaluations, surgical carve-out benefit administration, temporary health professional staffing, emergency youth detention medical services, and independent medical evaluations — none of which involve restriction of mesenteric artery or percutaneous extraluminal device placement. State and local procurement systems have not used this code to solicit vascular interventional devices or related services in the recent opportunities captured.

The issuing bodies include county health systems (Santa Clara Health System, Harris County Juvenile Probation Department), municipal retirement offices (City of Phoenix Retirement Office), state transportation departments (Washington State Department of Transportation), county government (Collier County Board of County Commissioners), and municipal employee benefits offices (City of Long Beach). Geographic activity spans California, Florida, Arizona, Washington, and Texas. The mismatch between code taxonomy and actual procurement intent suggests either misclassification at the time of opportunity posting or a code that has drifted from active use in state and local markets. Firms pursuing contracting in health services, occupational medicine, pharmacy administration, or benefits consulting should monitor this code's actual deployment in their target jurisdictions rather than assume alignment with its nominal device classification.